Description
Generic Version of Nilotinib Available in India?
Nilotinib is the generic name of the medication and is its international nonproprietary name. Nilotinib is marketed under the brand name KNILONAT among others. It is an anti-cancer medication used to treat chronic myelogenous leukemia (CML) which has the Philadelphia chromosome. It may be used both in initial cases of chronic phase CML as well as in accelerated and chronic phase CML that has not responded to imatinib.
Common side effects may include low platelets, low white blood cells, anemia, rashes, vomiting, diarrhea, and joint pains. Other serious side effects may include QT prolongation, sudden death, pancreatitis, and liver problems. It is not safe for use during pregnancy. Nilotinib is a Bcr-Abl tyrosine kinase inhibitor and works by interfering with signalling within the cancer cell.
Nilotinib was approved for medical use in the United States in 2007. It is approved as a generic medication.
Will this product be accessible across all regions of India?
The product – KNILONAT (Nilotinib) Capsule will be available across India on request. Nilotinib is available in all the major cities in India – Delhi, Chandigarh, Jodhpur, Patna, Kolkata, Lucknow, Hyderabad, Chennai, Ahmedabad, Bangalore, and Pune. To get or place an order from Aark Pharmaceuticals, a pharma distributor in India, please call us at+91 9999156233, You can also make an inquiry by emailing us at sales@aarkpharma.co.in, sales@aarkpharma.com, WhatsApp: +91 9999156233.
List of available brand-name drugs in India for Nilotinib
Branded Generic Drugs for Nilotinib: KNILONAT
NEWS / Updates
- Robert J. Thomson; Majid Moshirfar; Yasmyne Ronquillo; Tyrosine Kinase Inhibitors, [Revised on 21st Jan 2021]; [Accessed on 22st April 2023]; https://www.ncbi.nlm.nih.gov/books/NBK563322/
- Novartis Pharmaceuticals UK Ltd, Electronic Medicines Compendium (EMC), [Revised on May 2022], [Accessed on 21st April 2023], https://www.medicines.org.uk/emc/product/5852
- Novartis, US Food & Drug Administration, [Revised on Sep 2021], [Accessed on 21st April 2023], https://www.novartis.us/sites/www.novartis.us/files/tasigna.pdf?
Written By
Mr. Sandeep Tomar (D. pharma)
Last updated
01 | June 2025 | 07:25 AM (IST)